Checkpoint inhibitors in endometrial cancer: preclinical rationale and clinical activity

CONTEXT: Treatment of advanced and recurrent endometrial cancer (EC) is still an unmet need for oncologists and gynecologic oncologists. The Cancer Genome Atlas Research Network (TCGA) recently provided a new genomic classification, dividing EC in four subgroups. Two types of EC, the polymerase epsi...

Descripción completa

Detalles Bibliográficos
Autores principales: Mittica, Gloria, Ghisoni, Eleonora, Giannone, Gaia, Aglietta, Massimo, Genta, Sofia, Valabrega, Giorgio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685772/
https://www.ncbi.nlm.nih.gov/pubmed/29163851
http://dx.doi.org/10.18632/oncotarget.20042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685772/
https://www.ncbi.nlm.nih.gov/pubmed/29163851
http://dx.doi.org/10.18632/oncotarget.20042

Ejemplares similares